TY  - RPRT
TI  - Silmitasertib, an FDA-designated orphan CK2 Inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington's disease mouse model
AU  - Pelzel, R.
AU  - Herbst, M. A.
AU  - Rozema, N. B.
AU  - Solem, M. A.
AU  - Gomez-Pastor, R.
PY  - 2025
DO  - 10.1101/2025.11.19.689275
UR  - https://www.biorxiv.org/content/10.1101/2025.11.19.689275v1
ID  - 10.1101/2025.11.19.689275
ER  -